Overview
All of DR.Cure’s research and development activities are aimed at improving the quality of human life. DR.Cure promises to establish itself as a leading company in the global nanotherapeutcis industry through constant challenges and focused research.
DR.Cure is dedicated to researching nanotechnology-based radiotherapeutic nanoparticles and developing effective cancer treatments.
By leveraging innovative drug delivery systems and nanomedicine, we maximize treatment efficacy and continuously validate our expertise through patent applications and academic research.
Swipe the screen to the right
| Class | Nanomedicines | Target diseases | Hit discovery | Lead optimization |
Preclinical | Clinical |
| Radiotherapeutics for cancers |
DC-101 | Rectal cancer | ||||
| DC-102 | Liver cancer | |||||
| Nanomedicines for inflammatory diseases |
DC-201 | Arthritis |

